These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35810563)

  • 21. The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma.
    Uryvaev A; Passhak M; Hershkovits D; Sabo E; Bar-Sela G
    Med Oncol; 2018 Jan; 35(3):25. PubMed ID: 29388007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
    Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer.
    Rakaee M; Kilvaer TK; Dalen SM; Richardsen E; Paulsen EE; Hald SM; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Busund LT
    Hum Pathol; 2018 Sep; 79():188-198. PubMed ID: 29885403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.
    Althobiti M; Aleskandarany MA; Joseph C; Toss M; Mongan N; Diez-Rodriguez M; Nolan CC; Ashankyty I; Ellis IO; Green AR; Rakha EA
    Histopathology; 2018 Dec; 73(6):887-896. PubMed ID: 29947077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages.
    Kono-Sato T; Miyai K; Yamagishi Y; Miyamoto M; Takano M; Matsukuma S; Sato K; Tsuda H
    BMC Cancer; 2022 Apr; 22(1):361. PubMed ID: 35366828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas.
    Rapp C; Dettling S; Liu F; Ull AT; Warta R; Jungk C; Roesch S; Mock A; Sahm F; Schmidt M; Jungwirth G; Zweckberger K; Lamszus K; Gousias K; Kessler AF; Grabe N; Loehr M; Ketter R; Urbschat S; Senft C; Westphal M; Abdollahi A; Debus J; von Deimling A; Unterberg A; Simon M; Herold-Mende CC
    Clin Cancer Res; 2019 Sep; 25(17):5260-5270. PubMed ID: 31227506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.
    Thomas NE; Busam KJ; From L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Groben PA; Hao H; Orlow I; Reiner AS; Luo L; Paine S; Ollila DW; Wilcox H; Begg CB; Berwick M
    J Clin Oncol; 2013 Nov; 31(33):4252-9. PubMed ID: 24127443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.
    Lundgren C; Bendahl PO; Ekholm M; Fernö M; Forsare C; Krüger U; Nordenskjöld B; Stål O; Rydén L
    Breast Cancer Res; 2020 Dec; 22(1):140. PubMed ID: 33357231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationships between PD-L1 expression, CD8+ TILs and clinico-histomorphological parameters in malignant melanomas.
    Škuciová V; Drahošová S; Výbohová D; Cígerová V; Adamkov M
    Pathol Res Pract; 2020 Sep; 216(9):153071. PubMed ID: 32825944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Retrospective, Observational Analysis of Tumor Infiltrating Lymphocytes and Tumor Regression in Melanoma.
    Zaladonis A; Farma J; Hill M; Hotz M; Meller K; Board T; Deng M; Wu H; Reddy S; O'Halloran E
    J Surg Res; 2021 Nov; 267():203-208. PubMed ID: 34153563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue-Infiltrating Lymphocytes as a Predictive Factor for Recurrence in Patients with Curatively Resected Colon Cancer: A Propensity Score Matching Analysis.
    Chan LF; Sadahiro S; Suzuki T; Okada K; Miyakita H; Yamamoto S; Kajiwara H
    Oncology; 2020; 98(10):680-688. PubMed ID: 32526753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis.
    Ibrahim EM; Al-Foheidi ME; Al-Mansour MM; Kazkaz GA
    Breast Cancer Res Treat; 2014 Dec; 148(3):467-76. PubMed ID: 25361613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study.
    Signore A; Annovazzi A; Barone R; Bonanno E; D'Alessandria C; Chianelli M; Mather SJ; Bottoni U; Panetta C; Innocenzi D; Scopinaro F; Calvieri S
    J Nucl Med; 2004 Oct; 45(10):1647-52. PubMed ID: 15471828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
    Wang K; Shen T; Siegal GP; Wei S
    Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma.
    Naimy S; Bzorek M; Eriksen JO; Løvendorf MB; Litman T; Dyring-Andersen B; Gjerdrum LMR
    Dermatology; 2024; 240(1):156-163. PubMed ID: 37952520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.
    Haanen JB; Baars A; Gomez R; Weder P; Smits M; de Gruijl TD; von Blomberg BM; Bloemena E; Scheper RJ; van Ham SM; Pinedo HM; van den Eertwegh AJ
    Cancer Immunol Immunother; 2006 Apr; 55(4):451-8. PubMed ID: 16034562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the presence of tumor-infiltrating lymphocytes predictive of outcomes in patients with melanoma?
    Morrison SL; Han G; Elenwa F; Vetto JT; Fowler G; Leong SP; Kashani-Sabet M; Pockaj BA; Kosiorek HE; Zager JS; Sondak VK; Messina JL; Mozzillo N; Schneebaum S; Han D;
    Cancer; 2022 Apr; 128(7):1418-1428. PubMed ID: 35103302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of tumor infiltrating lymphocytes in sinonasal mucosal melanoma and prognosis for patients.
    Yin G; Guo W; Liu H; Huang Z; Chen X
    Curr Probl Cancer; 2022 Aug; 46(4):100878. PubMed ID: 35752137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer.
    Bai Y; Cole K; Martinez-Morilla S; Ahmed FS; Zugazagoitia J; Staaf J; Bosch A; Ehinger A; Nimeus E; Hartman J; Acs B; Rimm DL
    Clin Cancer Res; 2021 Oct; 27(20):5557-5565. PubMed ID: 34088723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor Infiltrating Lymphocytes are Prognostic Factors and Can Be Markers of Sensitivity to Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma.
    Suzuki H; Kawasaki Y; Miura M; Hatakeyama H; Shina K; Suzuki S; Yamada T; Suzuki M; Ito A; Omori Y
    Asian Pac J Cancer Prev; 2022 Apr; 23(4):1271-1278. PubMed ID: 35485685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.